Uncategorized

Short-term safety was confirmed. Efficacy including visual acuity and corneal thickness is improving.

Aadi Bioscience, Inc. announced that it presented data from its PRECISION 1 and AMPECT trials in two posters at the Society of Gynecological Oncology Annual Meeting 2023, taking place March 25-28, 2023, in Tampa, FL.

ImmunoGen, Inc. announced final overall survival data and an evaluation of sequence of therapy in the pivotal SORAYA trial of mirvetuximab soravtansine in patients with folate receptor alpha-high platinum-resistant ovarian cancer who had been previously treated with bevacizumab will be presented by Dr. Robert Coleman in a plenary session on Saturday, March 25, at the

Hoffmann-La Roche Limited announced that on March 24, 2023 Health Canada authorized COLUMVI® for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma not otherwise specified, DLBCL arising from follicular lymphoma, or primary mediastinal B-cell lymphoma, who have received two or more lines of systemic therapy and are ineligible to receive

The FDA is expected to make decisions on Emergent BioSolutions’ sNDA for OTC Narcan and Roche’s Polivy in frontline DLBCL.

Relmada Therapeutics announced it would make key changes to its clinical evaluation of REL-1017 as a possible add-on treatment for major depressive disorder.

Estudio poblacional de 20 años en UK muestra una mayor mortalidad por cáncer en personas con diabetes tipo 2

En este Short os hablamos de fumarolas submarinas que actúan como ecosistema para un tipo particular de microbios.     …

El Telescopio Espacial James Webb ha captado, más detalladamente que lo conseguido en cualquier otra observación previa comparable, el aspecto una estrella que se halla en una fase poco común, algo anterior a la explosión en forma de supernova de la estrella. Una supernov …

The extra liability coverage shows the directors feared unspecified consequences from closing the acquisition of Grail, according to the activist investor.